2025-01-29 16:15 | CC:OPTI | Optimi Health Corp | 0.22 | News Release200 | Optimi completes production batch of 4k MDMA capsules |
2025-01-29 00:45 | CC:OPTI | Optimi Health Corp | 0.205 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
2025-01-29 00:45 | CC:OPTI | Optimi Health Corp | 0.205 | SEDAR MD & A815 | SEDAR MD & A |
2025-01-28 21:09 | CC:OPTI | Optimi Health Corp | 0.205 | News Release200 | Optimi closes $395,000 final tranche of placement |
2025-01-17 17:49 | CC:OPTI | Optimi Health Corp | 0.225 | News Release200 | Optimi Health to close $395,000 final tranche financing |
2025-01-13 17:20 | CC:OPTI | Optimi Health Corp | 0.20 | News Release200 | Optimi Health exports psilocybin extract to New Zealand |
2025-01-06 17:04 | CC:OPTI | Optimi Health Corp | 0.23 | News Release200 | Optimi Health completes second shipment to Australia |
2024-12-17 17:16 | CC:OPTI | Optimi Health Corp | 0.225 | News Release200 | Optimi Health signs agreement with Psyence Biomedical |
2024-10-23 13:21 | CC:OPTI | Optimi Health Corp | 0.23 | News Release200 | Optimi doses 1st group of Australian patients with MDMA |
2024-10-21 15:39 | CC:OPTI | Optimi Health Corp | 0.185 | News Release200 | Optimi Health's Ciprick resigns as CEO |
2024-08-29 03:48 | CC:OPTI | Optimi Health Corp | 0.305 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-08-29 03:36 | CC:OPTI | Optimi Health Corp | 0.305 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-08-28 13:16 | CC:OPTI | Optimi Health Corp | 0.295 | News Release200 | Optimi receives no objection letter for phase 2 trial |
2024-08-16 11:31 | CC:OPTI | Optimi Health Corp | 0.30 | News Release200 | Optimi completes export of MDMA capsules to Australia |
2024-08-13 16:04 | CC:OPTI | Optimi Health Corp | 0.305 | News Release200 | Optimi Health signs LOI with Psyence Biomedical |
2024-08-07 12:13 | CC:OPTI | Optimi Health Corp | 0.325 | News Release200 | Optimi Health arranges $5-million private placement |
2024-07-23 15:07 | CC:OPTI | Optimi Health Corp | 0.335 | News Release200 | Optimi Health, PsiloThai to conduct psilocybin research |
2024-06-27 13:48 | CC:OPTI | Optimi Health Corp | 0.32 | News Release200 | Optimi Health launches OptiMed |
2024-06-25 14:42 | CC:OPTI | Optimi Health Corp | 0.32 | News Release200 | Optimi receives three export permits from Health Canada |
2024-06-11 12:27 | CC:OPTI | Optimi Health Corp | 0.37 | News Release200 | Optimi Health completes 1st shipment to Israel |
2024-06-04 09:15 | CC:OPTI | Optimi Health Corp | 0.47 | In the News525 | FP/wire say Optimi Health gets export licence |
2024-06-03 11:55 | CC:OPTI | Optimi Health Corp | 0.43 | Resume Trading385 | Optimi Health to resume at 9:15 a.m. PT |
2024-06-03 11:52 | CC:OPTI | Optimi Health Corp | 0.47 | News Release200 | Optimi receives DEL to make, sell MDMA, psilocybin |
2024-06-03 08:01 | CC:OPTI | Optimi Health Corp | 0.43 | Halt Trading170 | Optimi Health halted at the open |
2024-05-31 10:35 | CC:OPTI | Optimi Health Corp | 0.44 | News Release200 | Optimi Health closes $544,990 final financing tranche |
2024-05-31 01:53 | CC:OPTI | Optimi Health Corp | 0.44 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-05-31 01:10 | CC:OPTI | Optimi Health Corp | 0.44 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-05-29 12:22 | CC:OPTI | Optimi Health Corp | 0.40 | News Release200 | Optimi Health receives Australian import permit |
2024-05-22 12:16 | CC:OPTI | Optimi Health Corp | 0.375 | News Release200 | Optimi signs LOI to provide GMP psilocybin to ATMA |
2024-05-14 13:01 | CC:OPTI | Optimi Health Corp | 0.36 | News Release200 | Optimi Health receives COA for 40mg, 60mg MDMA capsules |
2024-05-10 11:29 | CC:OPTI | Optimi Health Corp | 0.385 | News Release200 | Optimi Health plans close of final tranche of financing |
2024-05-09 13:10 | CC:OPTI | Optimi Health Corp | 0.38 | News Release200 | Optimi Health receives export permit from Health Canada |
2024-04-23 11:47 | CC:OPTI | Optimi Health Corp | 0.33 | News Release200 | Optimi partners with Kwantlen psilocybin research |
2024-04-15 12:53 | CC:OPTI | Optimi Health Corp | 0.255 | News Release200 | Optimi Health completes three batches of MDMA API |
2024-04-09 15:03 | CC:OPTI | Optimi Health Corp | 0.265 | News Release200 | Optimi Health signs psilocybin supply agreement |
2024-04-02 11:30 | CC:OPTI | Optimi Health Corp | 0.245 | News Release200 | Optimi receives GMP analysis certificate for psilocybin |
2024-03-26 11:28 | CC:OPTI | Optimi Health Corp | 0.23 | News Release200 | Optimi to supply MDMA to Tel Aviv University |
2024-03-01 00:40 | CC:OPTI | Optimi Health Corp | 0.265 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-03-01 00:40 | CC:OPTI | Optimi Health Corp | 0.265 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-02-28 11:52 | CC:OPTI | Optimi Health Corp | 0.29 | News Release200 | Optimi Health closes $555,010 first financing tranche |